Speaker: Chris Wroten, OD
Length: 2 Hour
Date: Thursday, April 2
Time: 7:00 PM ETD
COPE ID: #65748-PH (LIVE CE)
COPE Activity: #119158
A fast-paced, multimedia look at emerging pharmaceuticals,novel drug delivery systems, innovative "eye tech", and advances in ophthalmic surgery. Also discussed will be cutting edge stem cell and gene therapy research and new diagnostic and therapeutic innovations poised to impact eye care.
NOTE: COPE has approved this course as LIVE CE. You will receive the same credit as if you attended a live face-to-face CE event.
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds
;klasjd;fkljasd;fkljsdkla/lskjdf ;lkajsd ;flkjas dl;fikj a;sldjkf ;laksjd f;ljkasd;flkja sdl;kfjasd
a’sdkjf;alksjdfl;kasjd
a sd’;fkj al;skdjf ;lkasdj f;lkjasd ;lfkjds